Open Payments

NEWYORK-PRESBYTERIAN/QUEENS

Type
Teaching hospital
Where
FLUSHING, NY
Medicare CCN
330055
Received
$459,431 in 104 records, 2020 ($203,429 general, $256,001 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment37$203,429
2020Research payment67$256,001

By company

CompanyRecordsAmountYears
Surgical Theater. Inc.2$144,0002020
Gilead Sciences, Inc.6$65,6122020
Novartis Pharmaceuticals Corporation1$64,2112020
Novocure Inc.6$61,3392020
Abbott Laboratories21$27,5062020
Pacira Therapeutics, Inc.1$24,1132020
BIOTRONIK INC.51$21,0742020
Bio-Rad Laboratories, Inc.4$13,4492020
SWEDISH ORPHAN BIOVITRUM AB1$12,2962020
Boston Scientific Corporation2$9,8892020
Linvatec Corporation2$4,4012020
Smith+Nephew, Inc.1$3,6062020
Genentech USA, Inc.1$3,0002020
AstraZeneca Pharmaceuticals LP2$2,5002020
LANTHEUS MEDICAL IMAGING, INC.1$1,7502020
FUJIFILM Healthcare Americas Corporation1$6142020
Siemens Medical Solutions USA, Inc.1$692020

By nature of payment

NatureRecordsAmount
Research payment67$256,001
Gift8$161,669
Consulting Fee15$10,936
Charitable Contribution2$9,262
Space rental or facility fees (teaching hospital only)5$9,000
Compensation for services other than consulting, including serving as faculty or as a speaker at a v5$8,160
Grant2$4,401

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Linvatec Corporation$2,250GrantIn-kind items and servicesMICROPOWER Device, ORTHOPEDIC SURGERY2020
2020-12-31Siemens Medical Solutions USA, Inc.$69Charitable ContributionIn-kind items and services2020
2020-12-23Gilead Sciences, Inc.$9,313Research paymentCash or cash equivalentA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2020
2020-12-23Abbott Laboratories$6,240Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentConfirm Rx Device, Cardiac Arrhythmias and Heart Failure2020
2020-12-10AstraZeneca Pharmaceuticals LP$750Space rental or facility fees (teaching hospital only)Cash or cash equivalentIMFINZI Drug, Oncology2020
2020-12-09Abbott Laboratories$290Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-12-08BIOTRONIK INC.$1,600Consulting FeeCash or cash equivalent2020
2020-12-08BIOTRONIK INC.$1,200Consulting FeeCash or cash equivalent2020
2020-12-08BIOTRONIK INC.$400Consulting FeeCash or cash equivalent2020
2020-12-08BIOTRONIK INC.$400Consulting FeeCash or cash equivalent2020
2020-11-18Gilead Sciences, Inc.$1,364Research paymentCash or cash equivalentA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2020
2020-10-30Novocure Inc.$8,588Research paymentCash or cash equivalentOptune Device, OncologyEF-27 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and2020
2020-10-26SWEDISH ORPHAN BIOVITRUM AB$12,296Research paymentCash or cash equivalentKINERET Drug, IMMUNOLOGYSOBI.IMMUNO-1012020
2020-10-15Boston Scientific Corporation$696Research paymentIn-kind items and servicesGENERAL - TACHY Device, TACHYLONGEVITY STUDY2020
2020-09-29Bio-Rad Laboratories, Inc.$10,038GiftCash or cash equivalentLiquichek Device, Controls2020
2020-09-29Bio-Rad Laboratories, Inc.$1,141GiftCash or cash equivalentDigital PCR Assays Device, PCR2020
2020-09-29Bio-Rad Laboratories, Inc.$1,135GiftCash or cash equivalentLipid Transfection Reagents Device, Not Applicable2020
2020-09-29Bio-Rad Laboratories, Inc.$1,135GiftCash or cash equivalentLipid Transfection Reagents Device, Not Applicable2020
2020-09-28Abbott Laboratories$500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-09-23Gilead Sciences, Inc.$1,364Research paymentCash or cash equivalentA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2020
2020-09-17Abbott Laboratories$4,615Research paymentCash or cash equivalentABSORB Device, VascularABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)2020
2020-09-17Abbott Laboratories$3,900Research paymentCash or cash equivalentABSORB Device, VascularABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)2020
2020-09-17Linvatec Corporation$2,151GrantIn-kind items and servicesFLUID MANAGEMENT/PUMPS Device, ORTHOPEDIC SURGERY2020
2020-08-25Novocure Inc.$13,490Research paymentCash or cash equivalentOptune Device, OncologyEF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi2020
2020-08-25Novocure Inc.$11,506Research paymentCash or cash equivalentOptune Device, OncologyEF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi2020
2020-08-24Gilead Sciences, Inc.$19,433Research paymentCash or cash equivalentVeklury Drug, COVID-19Phase 3 Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734) tre2020
2020-08-14Pacira Therapeutics, Inc.$24,113Research paymentCash or cash equivalentA Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Pat2020
2020-07-28BIOTRONIK INC.$400Consulting FeeCash or cash equivalent2020
2020-07-22Novocure Inc.$14,779Research paymentCash or cash equivalentOptune Device, OncologyEF-27 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and2020
2020-07-09Abbott Laboratories$1,248Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$660Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$660Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-09Abbott Laboratories$624Consulting FeeCash or cash equivalentFortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure2020
2020-07-06Genentech USA, Inc.$3,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentActivase Biological, Metabolism & Primary Care2020
2020-06-16Abbott Laboratories$325Research paymentCash or cash equivalentXience Sierra Coronary Stent System Device, VascularXIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients2020
2020-05-04Gilead Sciences, Inc.$17,069Research paymentCash or cash equivalentA Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt2020
2020-05-04Gilead Sciences, Inc.$17,069Research paymentCash or cash equivalentA Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib2020
2020-04-13FUJIFILM Healthcare Americas Corporation$614GiftIn-kind items and servicesESD - Core Endoscopy Device, Medical Device2020
2020-04-07Boston Scientific Corporation$9,193Charitable ContributionIn-kind items and servicesGeneral Therapies Device, General2020
2020-03-31BIOTRONIK INC.$12,359Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-03-12Abbott Laboratories$1,495Research paymentCash or cash equivalentABSORB Device, VascularABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)2020
2020-03-06Novocure Inc.$8,030Research paymentCash or cash equivalentOptune Device, OncologyEF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi2020
2020-02-27LANTHEUS MEDICAL IMAGING, INC.$1,750Space rental or facility fees (teaching hospital only)Cash or cash equivalentDEFINITY Drug, CONTRAST AGENT2020
2020-02-26Abbott Laboratories$565Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-02-26Abbott Laboratories$565Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-02-25AstraZeneca Pharmaceuticals LP$1,750Space rental or facility fees (teaching hospital only)Cash or cash equivalentLOKELMA Drug, Cardiovascular and Metabolism2020
2020-02-12Abbott Laboratories$1,750Space rental or facility fees (teaching hospital only)Cash or cash equivalentCardiac Mapping System Device, Cardiac Arrhythmias and Heart Failure2020
2020-02-11BIOTRONIK INC.$290Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$269Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$269Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$269Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$248Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$248Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$206Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$206Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$131Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$131Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$110Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$110Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$84Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$84Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$42Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$42Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$21Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-02-11BIOTRONIK INC.$21Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-29Smith+Nephew, Inc.$3,606GiftIn-kind items and servicesGENESIS II Device, Recon Knees2020
2020-01-20Abbott Laboratories$325Research paymentCash or cash equivalentXience Sierra Coronary Stent System Device, VascularXIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients2020
2020-01-15Novocure Inc.$4,945Research paymentCash or cash equivalentOptune Device, OncologyEF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi2020
2020-01-13Novartis Pharmaceuticals Corporation$64,211Research paymentCash or cash equivalentENTRESTO Drug, CARDIOVASCULARPROSPECTIVE COMPARISON OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR ARNI VERSUS ACE INHIBITOR TRIAL TO DETERMINE IMPACT 2020
2020-01-08BIOTRONIK INC.$347Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$269Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$269Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$269Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$33Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-08BIOTRONIK INC.$32Research paymentCash or cash equivalentSentus Device, Cardiology/Vascular DiseasesQP ExCELs2020
2020-01-01Surgical Theater. Inc.$72,000GiftIn-kind items and services2020
2020-01-01Surgical Theater. Inc.$72,000GiftIn-kind items and services2020

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

In New York; placed by its state only.

MeasureState
New York
Population B0100319,852,366
Population, 2020 census P120,201,249
Median age B0100239.8
Under 18 B0100120.5%
65 and over B0100117.9%
Households B110017,722,646
Foreign born B0500222.8%
Median household income B19013$85,974
Median family income B19113$106,873
Per capita income B19301$50,712
Poverty rate B1700114.0%
Unemployment rate B230256.4%
Civilian labor force B2302510,171,766
Mean commute (minutes) B0801332.6
Bachelor's degree or higher B1500340.2%
Housing units B250018,585,241
Owner-occupied B2500354.3%
Renters B2500345.7%
Median home value B25077$423,800
Median gross rent B25064$1,621
White, not Hispanic B0300252.8%
Black B0300213.4%
Hispanic or Latino B0300219.8%
Asian B030029.0%
American Indian and Alaska Native B030020.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New York.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.